This research shows enhanced drug release kinetics of in situ forming implants, indicating SORS as a viable formulation monitoring tool.
In situ forming implants (ISFIs) present a promising approach for sustained parenteral drug delivery, offering reduced first pass metabolism, fewer systemic side effects, and improved patient compliance. This study investigates defocused spatially-offset Raman spectroscopy (SORS) as a real-time, non-invasive, and label-free method for monitoring implant formation and drug release from ISFIs loaded with the model drugs 4-cyanophenol (4-CP) or all-trans retinoic acid (RA). A custom-designed flow-through diffusion cell, incorporating full-thickness porcine skin, was developed to enable ex vivo release studies, allowing simultaneous defocused SORS measurements of subcutaneously-implanted formulations and HPLC quantification of drug released into the receptor medium. Confocal Raman microscopy cross-section imaging validated defocused SORS findings, while static ex vivo release studies using Franz diffusion cells served as a reference for flow-through experiments. Both Franz cell and flow-through release studies revealed a pronounced burst release for the hydrophilic 4-CP after injection (90.7 % and 94.8 % released after 2.5 d under static and flow-through conditions, respectively) and a delayed, attenuated release for the hydrophobic RA (3.3 % and 2.1 % after 2.5 d). Defocused SORS further confirmed a correlation between implant formation and drug release, highlighting solvent exchange as a key driver of burst release. These findings demonstrate the unique capability of defocused SORS for the comprehensive, non-invasive, and real-time characterization of ISFI formulations. By combining the relevance of biological tissue with experimental accessibility, the ex vivo flow-through configuration (enhanced by defocused SORS) provides a novel and powerful platform for formulation development and individualized therapeutic drug monitoring, with strong potential for clinical translation.
No takes yet. Share an insight, caveat, or question.
Rath et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: